Congenica named as genomic analysis platform in ‘100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report’, publication in the New England Journal of Medicine Congenica named as genomic analysis platform in ‘100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report’, publication in the New England Journal of Medicine Congenica has...

Congenica is Joint Winner of MIT Solve Horizon Prize Congenica is Joint Winner of MIT Solve Horizon Prize Award recognises the role of Congenica’s artificial intelligence initiative in using data to help rare disease patients get the right care faster...

Congenica Receives CE Mark for Genomic Analysis Software Congenica Receives CE Mark for Genomic Analysis Software Cambridge, United Kingdom – 21 July 2021 - Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data...

Congenica Receives CE Mark for Genomic Analysis Software Congenica Receives CE Mark for Genomic Analysis Software Cambridge, United Kingdom – 21 July 2021 - Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data...